These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2857050)

  • 1. Hypertensive hypertrophic cardiomyopathy of the elderly.
    Topol EJ; Traill TA; Fortuin NJ
    N Engl J Med; 1985 Jan; 312(5):277-83. PubMed ID: 2857050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hypertrophic cardiomyopathy with dilatation of the left ventricle and congestive heart failure: comparison with postmyocarditis cardiomegaly and hypertensive heart failure].
    Kawanishi H; Yokota Y; Hayakawa M; Kaku K; Kumaki T; Matsumoto K; Fujitani K; Ito Y; Inoh T; Fukuzaki H
    J Cardiogr; 1983 Sep; 13(3):537-50. PubMed ID: 6235295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of beta-blockers and Ca antagonists on diastolic function of the hypertrophied left ventricle: an echocardiographic study].
    Isobe M; Kashida M; Isshiki T; Koizumi K; Kuwako K; Umeda T; Yamaguchi T; Machii K; Suzuki K; Tohda E
    J Cardiogr; 1982 Dec; 12(4):939-52. PubMed ID: 6136549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Safety and tolerability of beta-blockers in severe cardiac decompensation from dilated cardiomyopathy].
    Sinagra G; Perkan A; Zecchin M; Di Lenarda A; Lardieri G; Rakar S; Secoli G; Pinamonti B; Camerini F
    G Ital Cardiol; 1995 Oct; 25(10):1255-63. PubMed ID: 8682221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normalization of ejection fraction and resolution of symptoms in chronic severe heart failure is possible with modern medical therapy: clinical observations in 11 patients.
    Harinstein ME; Berliner JI; Shah SJ; Taegtmeyer H; Gheorghiade M
    Am J Ther; 2008; 15(3):206-13. PubMed ID: 18496257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium-antagonist receptors in the atrial tissue of patients with hypertrophic cardiomyopathy.
    Wagner JA; Sax FL; Weisman HF; Porterfield J; McIntosh C; Weisfeldt ML; Snyder SH; Epstein SE
    N Engl J Med; 1989 Mar; 320(12):755-61. PubMed ID: 2537929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Heart failure caused by severe systolic ventricular dysfunction of hypertensive origin. Long-term clinical and functional course].
    Anguita M; Castillo JC; Ramírez A; Siles JR; Ojeda S; Mesa D; Franco M; Vallés F
    Rev Esp Cardiol; 2000 Jul; 53(7):927-31. PubMed ID: 10944991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose dobutamine responsiveness in idiopathic dilated cardiomyopathy: relation to exercise capacity and clinical outcome.
    Scrutinio D; Napoli V; Passantino A; Ricci A; Lagioia R; Rizzon P
    Eur Heart J; 2000 Jun; 21(11):927-34. PubMed ID: 10806017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diastolic filling properties in different forms of left ventricular hypertrophy, assessed by 2-D echocardiography.
    Ruffmann K; Kücherer H; Mandelbaum A; Kübler W
    Z Kardiol; 1987; 76 Suppl 3():78-81. PubMed ID: 2963451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Reduced distensibility of the hypertensive heart under stress as an early sign of diastolic dysfunction].
    Plehn G; Schwartzkopff B
    Dtsch Med Wochenschr; 2005 Mar; 130(11):568-73. PubMed ID: 15761784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The calcium channel blocker felodipine attenuates the positive hemodynamic effects of the beta-blocker metoprolol in severe dilated cardiomyopathy--a prospective, randomized, double-blind and placebo-controlled study with invasive hemodynamic assessment.
    Braun M; Edelmann F; Knapp M; Schön S; Schwencke C; Simonis G; Borst M; Weinbrenner C; Strasser RH
    Int J Cardiol; 2009 Feb; 132(2):248-56. PubMed ID: 18579230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apical myectomy: a new surgical technique for management of severely symptomatic patients with apical hypertrophic cardiomyopathy.
    Schaff HV; Brown ML; Dearani JA; Abel MD; Ommen SR; Sorajja P; Tajik AJ; Nishimura RA
    J Thorac Cardiovasc Surg; 2010 Mar; 139(3):634-40. PubMed ID: 20176208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to isoproterenol as a prognostic indicator of evolution from hypertrophic cardiomyopathy to a phase resembling dilated cardiomyopathy.
    Kawano S; Iida K; Fujieda K; Yukisada K; Magdi ES; Iwasaki Y; Tabei F; Yamaguchi I; Sugishita Y
    J Am Coll Cardiol; 1995 Mar; 25(3):687-92. PubMed ID: 7860914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart rate variability in dilated cardiomyopathy.
    Biswas PK; Basu S; Mitra KK; Chowdhury SP; Chatterjee BP; Das Biswas A; Chatterjee SS; Maity AK
    Indian Heart J; 2000; 52(2):187-91. PubMed ID: 10893896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Beta blocking agents in the treatment of dilated cardiomyopathy: review of the literature and clinical experience with 67 patients].
    Sinagra G; Perkan A; Di Lenarda A; Lardieri G; Pinamonti B; Mestroni L; Miani D; Camerini F
    G Ital Cardiol; 1992 Aug; 22(8):969-89. PubMed ID: 1362167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of hypertension in apical hypertrophy].
    Fujiwara S; Umemoto M; Miyamoto Y; Ota A; Arita M; Yokote Y; Nakamura Y; Ueno Y; Nishio I; Masuyama Y
    J Cardiogr Suppl; 1985; (6):53-64. PubMed ID: 4067356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Calcium antagonists in cardiomyopathy].
    Takabatake Y
    Nihon Rinsho; 1991 Jan; 49(1):168-75. PubMed ID: 2002597
    [No Abstract]   [Full Text] [Related]  

  • 18. 10-year results and survival of patients with hypertrophic cardiomyopathy treated with calcium antagonists.
    Hopf R; Kaltenbach M
    Z Kardiol; 1987; 76 Suppl 3():137-44. PubMed ID: 3433866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diastolic function of the heart in clinical cardiology.
    Harizi RC; Bianco JA; Alpert JS
    Arch Intern Med; 1988 Jan; 148(1):99-109. PubMed ID: 2962556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms in cardiomyopathies.
    Goodwin JF
    J Mol Cell Cardiol; 1985 Jul; 17 Suppl 2():5-9. PubMed ID: 2863388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.